within Pharmacolibrary.Drugs.ATC.N;

model N03AG01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.3333333333333333e-07,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00019,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00016,
    k12             = 0.014,
    k21             = 0.014
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N03AG01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Valproic acid is an antiepileptic drug (AED) used primarily for the treatment of epilepsy, bipolar disorder, and prevention of migraine headaches. It is a broad-spectrum anticonvulsant approved for use in many countries, including the US and EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults after intravenous administration (bolus injection).</p><h4>References</h4><ol><li><p>Sitaruno, S, et al., &amp; Setthawatcharawanich, S (2024). Population Pharmacokinetics and Loading Dose Optimization of Intravenous Valproic Acid in Hospitalized Thai Patients. <i>Journal of clinical pharmacology</i> 64(11) 1343–1350. DOI:<a href=\"https://doi.org/10.1002/jcph.6102\">10.1002/jcph.6102</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39073986/\">https://pubmed.ncbi.nlm.nih.gov/39073986</a></p></li><li><p>Vidaurre, J, et al., &amp; Yarosz, S (2017). Antiepileptic Drugs and Liver Disease. <i>Pediatric neurology</i> 77 23–36. DOI:<a href=\"https://doi.org/10.1016/j.pediatrneurol.2017.09.013\">10.1016/j.pediatrneurol.2017.09.013</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29097018/\">https://pubmed.ncbi.nlm.nih.gov/29097018</a></p></li><li><p>Gziut, T, &amp; Thanacoody, R (2025). L-carnitine for valproic acid-induced toxicity. <i>British journal of clinical pharmacology</i> 91(3) 636–647. DOI:<a href=\"https://doi.org/10.1111/bcp.16233\">10.1111/bcp.16233</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39261302/\">https://pubmed.ncbi.nlm.nih.gov/39261302</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N03AG01_1;
